Selected research
Industry Research
Pharmacovigilance Solutions Industry Research Report 2026
Market perspective
The global Pharmacovigilance Solutions market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmacovigilance Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmacovigilance Solutions market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmacovigilance Solutions market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmacovigilance Solutions include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA and Parexel, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmacovigilance Solutions market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmacovigilance Solutions.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmacovigilance Solutions Market by Company
Eurofins Scientific
Accenture
PPD
SGS
WuXi AppTec
Cognizant
ICON
IQVIA
Parexel
United BioSource
Vial
Wipro
PrimeVigilance
Aixial Group
TransPerfect
ProPharma
HCLTech
QbD Group
Quanticate
Qinecsa Solutions
Veristat
Veeda
Tigermed
Clarivate
Pharmacovigilance Solutions Segment by Type
Writing and Submitting Documents and Reports
Security Database System Services and Data Management
Signal Detection and Evaluation
Training and Consulting
Other
Pharmacovigilance Solutions Segment by Application
Preclinical
Clinical Phase
Post-launch
Pharmacovigilance Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmacovigilance Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Writing and Submitting Documents and Reports
- Security Database System Services and Data Management
- Signal Detection and Evaluation
- Training and Consulting
- Other
Applications
- Preclinical
- Clinical Phase
- Post-launch
Companies covered
- Eurofins Scientific
- Accenture
- PPD
- SGS
- WuXi AppTec
- Cognizant
- ICON
- IQVIA
- Parexel
- United BioSource
- Vial
- Wipro
- PrimeVigilance
- Aixial Group
- TransPerfect
- ProPharma
- HCLTech
- QbD Group
- Quanticate
- Qinecsa Solutions
- Veristat
- Veeda
- Tigermed
- Clarivate
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmacovigilance Solutions by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Writing and Submitting Documents and Reports
- 2.2.3 Security Database System Services and Data Management
- 2.2.4 Signal Detection and Evaluation
- 2.2.5 Training and Consulting
- 2.2.6 Other
- 2.3 Pharmacovigilance Solutions by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Preclinical
- 2.3.3 Clinical Phase
- 2.3.4 Post-launch
- 2.4 Assumptions and Limitations
3 Pharmacovigilance Solutions Breakdown Data by Type
- 3.1 Global Pharmacovigilance Solutions Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmacovigilance Solutions Forecasted Market Size by Type (2027-2032)
4 Pharmacovigilance Solutions Breakdown Data by Application
- 4.1 Global Pharmacovigilance Solutions Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmacovigilance Solutions Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmacovigilance Solutions Market Perspective (2021-2032)
- 5.2 Global Pharmacovigilance Solutions Growth Trends by Region
- 5.2.1 Global Pharmacovigilance Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmacovigilance Solutions Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmacovigilance Solutions Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmacovigilance Solutions Market Dynamics
- 5.3.1 Pharmacovigilance Solutions Industry Trends
- 5.3.2 Pharmacovigilance Solutions Market Drivers
- 5.3.3 Pharmacovigilance Solutions Market Challenges
- 5.3.4 Pharmacovigilance Solutions Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmacovigilance Solutions Players by Revenue
- 6.1.1 Global Top Pharmacovigilance Solutions Players by Revenue (2021-2026)
- 6.1.2 Global Pharmacovigilance Solutions Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmacovigilance Solutions Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmacovigilance Solutions Head Office and Area Served
- 6.4 Global Pharmacovigilance Solutions Players, Product Type & Application
- 6.5 Global Pharmacovigilance Solutions Manufacturers Established Date
- 6.6 Global Pharmacovigilance Solutions Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmacovigilance Solutions Market Size (2021-2032)
- 7.2 North America Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmacovigilance Solutions Market Size by Country (2021-2026)
- 7.4 North America Pharmacovigilance Solutions Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmacovigilance Solutions Market Size (2021-2032)
- 8.2 Europe Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmacovigilance Solutions Market Size by Country (2021-2026)
- 8.4 Europe Pharmacovigilance Solutions Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmacovigilance Solutions Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmacovigilance Solutions Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmacovigilance Solutions Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmacovigilance Solutions Market Size (2021-2032)
- 10.2 South America Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmacovigilance Solutions Market Size by Country (2021-2026)
- 10.4 South America Pharmacovigilance Solutions Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmacovigilance Solutions Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.1.4 Eurofins Scientific Pharmacovigilance Solutions Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 Accenture
- 12.2.1 Accenture Company Information
- 12.2.2 Accenture Business Overview
- 12.2.3 Accenture Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.2.4 Accenture Pharmacovigilance Solutions Product Portfolio
- 12.2.5 Accenture Recent Developments
- 12.3 PPD
- 12.3.1 PPD Company Information
- 12.3.2 PPD Business Overview
- 12.3.3 PPD Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.3.4 PPD Pharmacovigilance Solutions Product Portfolio
- 12.3.5 PPD Recent Developments
- 12.4 SGS
- 12.4.1 SGS Company Information
- 12.4.2 SGS Business Overview
- 12.4.3 SGS Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.4.4 SGS Pharmacovigilance Solutions Product Portfolio
- 12.4.5 SGS Recent Developments
- 12.5 WuXi AppTec
- 12.5.1 WuXi AppTec Company Information
- 12.5.2 WuXi AppTec Business Overview
- 12.5.3 WuXi AppTec Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.5.4 WuXi AppTec Pharmacovigilance Solutions Product Portfolio
- 12.5.5 WuXi AppTec Recent Developments
- 12.6 Cognizant
- 12.6.1 Cognizant Company Information
- 12.6.2 Cognizant Business Overview
- 12.6.3 Cognizant Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.6.4 Cognizant Pharmacovigilance Solutions Product Portfolio
- 12.6.5 Cognizant Recent Developments
- 12.7 ICON
- 12.7.1 ICON Company Information
- 12.7.2 ICON Business Overview
- 12.7.3 ICON Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.7.4 ICON Pharmacovigilance Solutions Product Portfolio
- 12.7.5 ICON Recent Developments
- 12.8 IQVIA
- 12.8.1 IQVIA Company Information
- 12.8.2 IQVIA Business Overview
- 12.8.3 IQVIA Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.8.4 IQVIA Pharmacovigilance Solutions Product Portfolio
- 12.8.5 IQVIA Recent Developments
- 12.9 Parexel
- 12.9.1 Parexel Company Information
- 12.9.2 Parexel Business Overview
- 12.9.3 Parexel Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.9.4 Parexel Pharmacovigilance Solutions Product Portfolio
- 12.9.5 Parexel Recent Developments
- 12.10 United BioSource
- 12.10.1 United BioSource Company Information
- 12.10.2 United BioSource Business Overview
- 12.10.3 United BioSource Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.10.4 United BioSource Pharmacovigilance Solutions Product Portfolio
- 12.10.5 United BioSource Recent Developments
- 12.11 Vial
- 12.11.1 Vial Company Information
- 12.11.2 Vial Business Overview
- 12.11.3 Vial Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.11.4 Vial Pharmacovigilance Solutions Product Portfolio
- 12.11.5 Vial Recent Developments
- 12.12 Wipro
- 12.12.1 Wipro Company Information
- 12.12.2 Wipro Business Overview
- 12.12.3 Wipro Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.12.4 Wipro Pharmacovigilance Solutions Product Portfolio
- 12.12.5 Wipro Recent Developments
- 12.13 PrimeVigilance
- 12.13.1 PrimeVigilance Company Information
- 12.13.2 PrimeVigilance Business Overview
- 12.13.3 PrimeVigilance Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.13.4 PrimeVigilance Pharmacovigilance Solutions Product Portfolio
- 12.13.5 PrimeVigilance Recent Developments
- 12.14 Aixial Group
- 12.14.1 Aixial Group Company Information
- 12.14.2 Aixial Group Business Overview
- 12.14.3 Aixial Group Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.14.4 Aixial Group Pharmacovigilance Solutions Product Portfolio
- 12.14.5 Aixial Group Recent Developments
- 12.15 TransPerfect
- 12.15.1 TransPerfect Company Information
- 12.15.2 TransPerfect Business Overview
- 12.15.3 TransPerfect Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.15.4 TransPerfect Pharmacovigilance Solutions Product Portfolio
- 12.15.5 TransPerfect Recent Developments
- 12.16 ProPharma
- 12.16.1 ProPharma Company Information
- 12.16.2 ProPharma Business Overview
- 12.16.3 ProPharma Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.16.4 ProPharma Pharmacovigilance Solutions Product Portfolio
- 12.16.5 ProPharma Recent Developments
- 12.17 HCLTech
- 12.17.1 HCLTech Company Information
- 12.17.2 HCLTech Business Overview
- 12.17.3 HCLTech Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.17.4 HCLTech Pharmacovigilance Solutions Product Portfolio
- 12.17.5 HCLTech Recent Developments
- 12.18 QbD Group
- 12.18.1 QbD Group Company Information
- 12.18.2 QbD Group Business Overview
- 12.18.3 QbD Group Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.18.4 QbD Group Pharmacovigilance Solutions Product Portfolio
- 12.18.5 QbD Group Recent Developments
- 12.19 Quanticate
- 12.19.1 Quanticate Company Information
- 12.19.2 Quanticate Business Overview
- 12.19.3 Quanticate Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.19.4 Quanticate Pharmacovigilance Solutions Product Portfolio
- 12.19.5 Quanticate Recent Developments
- 12.20 Qinecsa Solutions
- 12.20.1 Qinecsa Solutions Company Information
- 12.20.2 Qinecsa Solutions Business Overview
- 12.20.3 Qinecsa Solutions Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.20.4 Qinecsa Solutions Pharmacovigilance Solutions Product Portfolio
- 12.20.5 Qinecsa Solutions Recent Developments
- 12.21 Veristat
- 12.21.1 Veristat Company Information
- 12.21.2 Veristat Business Overview
- 12.21.3 Veristat Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.21.4 Veristat Pharmacovigilance Solutions Product Portfolio
- 12.21.5 Veristat Recent Developments
- 12.22 Veeda
- 12.22.1 Veeda Company Information
- 12.22.2 Veeda Business Overview
- 12.22.3 Veeda Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.22.4 Veeda Pharmacovigilance Solutions Product Portfolio
- 12.22.5 Veeda Recent Developments
- 12.23 Tigermed
- 12.23.1 Tigermed Company Information
- 12.23.2 Tigermed Business Overview
- 12.23.3 Tigermed Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.23.4 Tigermed Pharmacovigilance Solutions Product Portfolio
- 12.23.5 Tigermed Recent Developments
- 12.24 Clarivate
- 12.24.1 Clarivate Company Information
- 12.24.2 Clarivate Business Overview
- 12.24.3 Clarivate Revenue in Pharmacovigilance Solutions Business (2021-2026)
- 12.24.4 Clarivate Pharmacovigilance Solutions Product Portfolio
- 12.24.5 Clarivate Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst